bibliographicCitation |
Takeda Y, Kataoka K, Yamagishi J, Ogawa S, Seya T, Matsumoto M. A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy. Cell Rep. 2017 May 30;19(9):1874–87. doi: 10.1016/j.celrep.2017.05.015. PMID: 28564605. |